9999999995-23-003062.txt : 20231024 9999999995-23-003062.hdr.sgml : 20231024 20231024001510 ACCESSION NUMBER: 9999999995-23-003062 CONFORMED SUBMISSION TYPE: EFFECT PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20231023 DATE AS OF CHANGE: 20231024 EFFECTIVENESS DATE: 20231023 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Akari Therapeutics Plc CENTRAL INDEX KEY: 0001541157 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 981034922 STATE OF INCORPORATION: X0 FILING VALUES: FORM TYPE: EFFECT SEC ACT: 1933 Act SEC FILE NUMBER: 333-267840 FILM NUMBER: 231341041 BUSINESS ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (646) 350-0702 MAIL ADDRESS: STREET 1: 22 BOSTON WHARF ROAD STREET 2: FL 7 CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Celsus Therapeutics Plc. DATE OF NAME CHANGE: 20130621 FORMER COMPANY: FORMER CONFORMED NAME: Morria Biopharmaceuticals PLC DATE OF NAME CHANGE: 20120201 EFFECT 1 primary_doc.xml X0101 EFFECT 33 LIVE 2023-10-23 0001104659-23-110512 POS AM 0001541157 Akari Therapeutics Plc 333-267840